---
title: "Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285611847.md"
description: "Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, \"Ginkgo\") issued a report on its financial performance for the initial quarter of 2026, concluded on March 31. The update comes subsequent to the sale of its Biosecurity division. On May 7, 2026, the company provided insights into its first-quarter results post the divestment. This announcement comes amidst a changing business landscape for Ginkgo as it navigates new strategic directions."
datetime: "2026-05-07T20:08:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285611847.md)
  - [en](https://longbridge.com/en/news/285611847.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285611847.md)
---

# Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") issued a report on its financial performance for the initial quarter of 2026, concluded on March 31. The update comes subsequent to the sale of its Biosecurity division. On May 7, 2026, the company provided insights into its first-quarter results post the divestment. This announcement comes amidst a changing business landscape for Ginkgo as it navigates new strategic directions.

### Related Stocks

- [DNA.US](https://longbridge.com/en/quote/DNA.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [DNABW.US](https://longbridge.com/en/quote/DNABW.US.md)

## Related News & Research

- [A Look At Iovance Biotherapeutics (IOVA) Valuation After Recent Share Price Recovery](https://longbridge.com/en/news/288161921.md)
- [Biohaven reports strong opakalim seizure control and MoDE/TRAP biomarker wins ahead of pivotal trials](https://longbridge.com/en/news/287823785.md)
- [09:00 ETThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA](https://longbridge.com/en/news/287639188.md)
- [Aligos Therapeutics Presents Positive Data at the EASL Congress 2026 | ALGS Stock News](https://longbridge.com/en/news/287726278.md)
- [How KT-621 Phase 1b Biomarker Data Could Shape Kymera Therapeutics' (KYMR) Oral Degrader Narrative](https://longbridge.com/en/news/287954497.md)